Microelectrode Array Systems for Cardiomyocyte Culture Assessment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing electrically active cell cultures, such as cardiomyocytes, face challenges in accurately evaluating the quality and stability of these cultures due to confounding variables like spatial and temporal variability, which can lead to unreliable data when testing pharmaceutical compounds, especially in pre-clinical testing before human clinical trials.
Innovation Solution
The use of microelectrode arrays (MEAs) to collect and analyze field potential signals from electrically active cells, allowing for the determination of parameters like cell density, arrhythmogenic behaviors, and conduction velocity, while also providing the ability to filter data and improve temporal and spatial stability through electrical stimulation, enabling more reliable inclusion in scientific studies and compound safety assessments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of time
If in vitro cell culture methods are used to eliminate unsafe compounds before animal testing, then time and expense are reduced, but data reliability is compromised due to spatial and temporal variability
Solution Approach 1:
The system continuously monitors electrical activity parameters (beat period, field potential duration, conduction velocity) from cardiomyocyte cultures and uses this feedback to assess compound safety in real-time, enabling reliable pre-clinical screening without animal testing
Solution Approach 2:
The patent replaces mechanical/physical animal testing systems with an electrical measurement system using microelectrode arrays to detect field potentials and action potentials from cultured cardiomyocytes, providing a reliable alternative that reduces time and ethical concerns
2Measurement precision
If microelectrode arrays are used to collect field potential signals from electrically active cells, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The system divides the measurement task across multiple microelectrodes arranged in arrays, with each electrode capturing local field potential signals that are then integrated computationally to provide comprehensive spatial and temporal characterization of cardiac electrical activity
Solution Approach 2:
The patent introduces specialized electronics and signal processing algorithms as intermediaries between the microelectrode arrays and the researcher, automatically filtering noise, detecting action potentials, and extracting physiological parameters to simplify the complex raw data into meaningful measurements
3Stability of the object's composition
If electrical stimulation is applied to improve temporal and spatial stability of cell cultures, then data consistency is improved, but the system requires additional control mechanisms increasing complexity
Solution Approach 1:
The system applies periodic electrical stimulation at controlled frequencies to synchronize cardiomyocyte beating and maintain consistent rhythm across the culture, ensuring temporal stability of electrical activity measurements throughout the experiment
Solution Approach 2:
The patent combines the stimulation and recording functions into an integrated system where the same microelectrode array can both deliver electrical stimuli and record resulting electrical activity, reducing the number of separate components needed
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the reduction of confounding variables, improving the reliability of data from electrically active cell cultures, enhancing the accuracy of compound safety evaluations and the quality assessment of cardiomyocyte cultures, thereby reducing the need for animal testing and streamlining the pre-clinical evaluation process.
Implementation Method 1
Microelectrode arrays (MEAs) to collect and analyze field potential signals from electrically active cells
Data Source
AI summary
Disclosed herein are systems and methods for assessing electrically active cell cultures. Optionally, the data can be collected using a microelectrode array (MEA). For example, electrically active cells, such as cardiomyocytes, are cultured such that they are in electrical communication with at least a portion of the electrodes of a well of the MEA. The assessments derived from the disclosed methods may be used to reduce the effects of confounding variables in data obtained from an electrically active cell culture. The methods may also be used to determine a quantitative measure of arrhythmia burden. The methods may also be used to decide if a particular culture or set of data is suitable for inclusion in scientific and characterization studies. Also disclosed is a method of finding the global conduction velocity of an electrically active cell culture.